Boston Scientific Corp (NYSE:BSX) currently has a daily average trading volume of 8.08M but it saw 9101115 shares traded in last market. With a market cap of 145.81B USD, the company’s current market price of $98.56 came falling about -0.85 while comparing to the previous closing price of $99.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $107.17 and as low as $71.88.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Needham which upgraded the stock as “Buy” in its note to investors issued on April 16, 2025, recommending a price target of $113 for it. Deutsche Bank upgraded its recommendation for the stock as a “Buy” from “Hold” on January 10, 2025 while assigning a price target of $108.
Over the week, BSX’s stock price is moving -4.15% down while it is -4.26% when we observe its performance for the past one month. Year-to-date it is 10.34% up and over the past year, the stock is showing an upside performance of 27.31%.
Currently, Boston Scientific Corp’s total number of outstanding shares is 1.48B with 0.18% of that held by the insiders while 93.27% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 6.13% and return on equity (ROE) at 9.65%. It has a price to earnings ratio (P/E ratio) of 72.22 while having a 29.92 of forward P/E ratio. Stock’s beta reads 0.68. Stock has a price to book (P/B) ratio of 6.56 while price to sale or P/S ratio amounts to 8.31. Its return on asset (ROA) is 5.29% on average.
